You're using an outdated browser. Please upgrade to a modern browser for the best experience.
Submitted Successfully!
Thank you for your contribution! You can also upload a video entry or images related to this topic. For video creation, please contact our Academic Video Service.
Version Summary Created by Modification Content Size Created at Operation
1 Sun-Wei Guo -- 1390 2023-01-10 03:30:44 |
2 format correct Conner Chen Meta information modification 1390 2023-01-10 08:18:59 |

Video Upload Options

We provide professional Academic Video Service to translate complex research into visually appealing presentations. Would you like to try it?
No, upload directly Yes

Confirm

Are you sure to Delete?
Yes No
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Guo, S.;  Benagiano, G.;  Bazot, M. Imaging-Based Classification of Adenomyosis. Encyclopedia. Available online: https://encyclopedia.pub/entry/39932 (accessed on 05 December 2025).
Guo S,  Benagiano G,  Bazot M. Imaging-Based Classification of Adenomyosis. Encyclopedia. Available at: https://encyclopedia.pub/entry/39932. Accessed December 05, 2025.
Guo, Sun-Wei, Giuseppe Benagiano, Marc Bazot. "Imaging-Based Classification of Adenomyosis" Encyclopedia, https://encyclopedia.pub/entry/39932 (accessed December 05, 2025).
Guo, S.,  Benagiano, G., & Bazot, M. (2023, January 10). Imaging-Based Classification of Adenomyosis. In Encyclopedia. https://encyclopedia.pub/entry/39932
Guo, Sun-Wei, et al. "Imaging-Based Classification of Adenomyosis." Encyclopedia. Web. 10 January, 2023.
Imaging-Based Classification of Adenomyosis
Edit
This entry is adapted from the peer-reviewed paper 10.3390/jcm12010287

Adenomyosis is a complex and poorly understood gynecological disease. Its diagnosis is carried out increasingly by imaging techniques, including transvaginal ultrasound (TVUS) and magnetic resonance imaging (MRI). However, the lack of a consensus on a classification system hampers relating imaging findings with disease severity or with the histopathological features of the disease, making it difficult to properly inform patients and clinicians regarding prognosis and appropriate management, as well as to compare different studies.

adenomyosis elastography fibrosis

1. The Tower of Babel

Featuring the presence of endometrial glands and stroma within the myometrium [1], adenomyosis is a uterine disease that affects many women of reproductive age and contributes to dysmenorrhea, pelvic pain, abnormal uterine bleeding (AUB)/heavy menstrual bleeding (HMB), and subfertility [2][3][4][5]. Consequently, it impacts negatively on the quality of life of the afflicted woman [6]. It is also associated with increased risk of several adverse pregnancy outcomes [3][7]. Due largely to its poorly understood pathogenesis and pathophysiology, its clinical management still poses a challenge [8] and will remain problematic until its various features can be linked to specific clinical symptoms, a difficult task because the symptoms of adenomyosis are not pathognomonic.
Dysmenorrhea, pelvic pain, AUB/HMB, and subfertility/infertility have been reported in 90.8% of affected women [9]; however, these conditions are unfortunately not specific to adenomyosis, and, as such, the diagnosis has to rely on other means [10]. The diagnosis of adenomyosis used to be determined solely by histology after hysterectomy, and, as such, it was found disproportionately in older, parous or perimenopausal women, with a prevalence ranging wildly from 10% to 88% [11]. With the advent of modern imaging technology, adenomyosis is increasingly diagnosed in a non-invasive fashion [12][13]. In the last three decades, transvaginal ultrasonography (TVUS) and magnetic resonance imaging (MRI) have gradually taken over the role of the post-hysterectomy histological evaluation as the principal diagnostic tool, and become the major diagnostic tools for adenomyosis.
For this reason and given the wild variation of adenomyosis in terms of location, pattern, size, and affected area, the one pressing issue is to classify the disease based on imaging diagnosis. Ideally, an established classification system should link the extent of the disease with symptoms, their severity, and/or prognostic indices [14][15][16]. It also should help to understand the pathogenesis, pathology, clinical manifestations of adenomyosis, suggest the best treatment modality, provide a prognosis, and if at all possible be capable of monitoring treatment response. Finally, since adenomyosis is still an under-investigated disease, a widely accepted classification system should allow improved comparisons of research data and clinical outcomes [17][18].
Due to these pressing needs, several image-based classification systems have been proposed [5][14][15][19][20][21][22] and summarized [23], but so far, no consensus has been reached. Recognizing the importance of an agreed classification, available information has been condensed in a number of reviews published over the last 15 years [5][15][16][23][24] and renewed efforts have been made towards a non-invasive ultrasound classification [25]. Unfortunately, so far, consensus has not been reached and without a consensus classification system, there is a real danger of repeating the catastrophic fiasco of building the Tower of Babel.

2. Imaging-Based Classification of Adenomyosis

Some classification systems have already demonstrated their utility in helping to understand adenomyosis better. For example, the Kishi system has helped people to understand that intrinsic adenomyosis, lesions that are confined to the subendometrial layer without involving the outermost myometrium, is often associated with the history of iatrogenic uterine procedure [19]. In addition, intrinsic adenomyosis is often associated with HMB while extrinsic or external adenomyosis is associated with pain [26].
Recently, Exacoustos et al. investigated the relation between an ultrasound-based disease classification and symptoms [25]. Women with ultrasound diagnosis of diffuse adenomyosis were older and had heavier menstrual bleeding compared to those with focal disease, but, when it came to the severity of dyspareunia and dysmenorrhea, there was no statistically significant difference. In contrast, focal adenomyosis was associated with a higher percentage of infertility. Overall, no direct correlation between ultrasound depictions of the extent of the disease and symptoms was found. The authors speculate that this may be related either to co-existent pathology, or to a true lack of correlation between symptoms and disease extent. However, better statistically powered studies will be warranted before definitive conclusions can be reached [25].
Table 1 summarizes various proposals for imaging-based classifications of adenomyosis. One conspicuous feature shared by all these proposals is that all of them attempted to correlate various classification parameters with either possible pathogenesis, or symptomatology or its severity. However, none of these parameters has been shown to be linked with the histological features of endometriotic lesions [23].
Table 1. Imaging-based classifications of adenomyosis proposed so far.
Author(s) and Year of Publication Imaging Platform Proposed Classification Rationale Remarks
Kishi et al. (2012) [19] MRI Four subtypes:
I: intrinsic;
II: extrinsic;
III: intramural;
IV: indeterminate		 Based on Sampson’s observation as well as clinical observations Subtypes I and II appear to have different pathogenesis, symptomology, and severity
Van den Bosch et al. (2015) [27]
Revised in Harmsen et al. (2022) [21]
(The MUSA standard)		 TVUS Direct features:
Cysts, hyperechogenic islands, echogenic subendometrial lines and buds.
Indirect features:
Asymmetrical thickening, globular uterus, irregular JZ, fan-shaped shadowing, translesional vascularity, interrupted JZ.		 Based on expert consensus through several rounds of modified Delphi procedure A welcome step towards the establishment of standardized terminology, with the goal to build a uniformly accepted or validated system to diagnose or classify the severity of adenomyosis based on imaging findings.
Bazot and Darai (2018) [14] MRI Three subtypes:
-Internal
-External
-Adenomyoma		 Based on Sampson’s observation as well as clinical observations Different subtypes appear to have different pathogenesis, symptomatology, and severity
Gordts et al. (2018) [5] MRI/TVUS/hysteroscopy Important parameters to be included in a classification system: Affected area (inner or outer myometrium), localization (anterior, posterior, or fundus), pattern (diffuse or focal), type (muscular or cystic), volume or size (expressed as <1/3, <2/3, >2/3 or in cm) These parameters are potentially related to symptomatology and/or severity Included parameters are important for accurate diagnosis and, through grading, may be associated with disease severity.
Van den Bosch et al. (2019) [28] TVUS Location (anterior, posterior, left or right lateral side, or fundus), differentiation (focal, diffuse, or mixed type), cysticity (cystic or non-cystic), uterine layer involvement (
I: involving inner/sub-endometrial myometrium;
II: involvement of middle myometrium;
III: involvement of outer/sub-serosal myometrium), extent (<1/4, ≥1/4 but ≤1/2, >1/2 myometrium), and size.		 Based on consensus among sonographers, and consistent with the previous MUSA consensus. A welcome first step towards an internationally accepted classification and reporting system
Kobayashi and Matsubara (2020) [20] MRI Five main categories: (1) affected area (internal vs. external), (2) pattern (diffuse, focal); (3) size (<1/3, <2/3, or >2/3 of uterine wall); and (4) localization (anterior, posterior, left lateral, right lateral, and fundus); (5) concomitant pathologies (none, PE, OE, DE, UF, others) Adopted from previous proposals of classification Combined all important features of adenomyosis that may be useful for proper classification
Exacoustos et al. (2020) [25] TVUS Type (focal, diffuse, or adenomyomas),
Extension of the lesion in the myometrium		 Empirical observations These variables seem to correlate with the severity of symptoms and infertility
Abbreviations used in the table: DE: deep endometriosis; JZ: junctional zone; MRI: magnetic resonance imaging; OE: ovarian endometrioma; PE: peritoneal endometriosis; UF: uterine fibroids.
All imaging classification systems proposed so far [5][14][15][19][20] are sensible. For example, part of Bazot and Darai’s system [14] as well as that of Kishi’s [19] can be traced back to the original Sampson’s grouping according to the origin or pathogenesis: invasion from within the uterus (arising from the uterine inner myometrial layer); invasion from outside the uterus (arising from the uterine outer myometrial layer); and misplaced endometrial tissue in the uterine wall (possibly arising from embryologically, solitary pluripotent Müllerian remnants) [14][20][29]. The intrinsic/internal type of adenomyosis also makes sense, since as early as 1908 Cullen was able to establish the physical continuity between eutopic and ectopic endometrium in many patients with adenomyosis [16][30]. This is demonstrated, using modern technology, by 3D rendition showing that adenomyosis lesions are stereoscopically characterized by an “ant colony-like network” that connects directly with endometrial glands [31].
These proposed classification types are a welcome step towards a homogenized system so that all gynecologists may speak the same language while some of them have been shown to be useful in separating different phenotypes. However, none of them has been shown to be able to stage adenomyosis, to correlate the severity of symptomology or have prognostic value. At best, a filing system can be established, upon which a patient could be classified into one of the classification categories, as shown recently [32].

References

  1. Bird, C.C.; McElin, T.W.; Manalo-Estrella, P. The elusive adenomyosis of the uterus—Revisited. Am. J. Obstet. Gynecol. 1972, 112, 583–593.
  2. Farquhar, C.; Brosens, I. Medical and surgical management of adenomyosis. Best Pract. Res. Clin. Obstet. Gynaecol. 2006, 20, 603–616.
  3. Harada, T.; Khine, Y.M.; Kaponis, A.; Nikellis, T.; Decavalas, G.; Taniguchi, F. The Impact of Adenomyosis on Women’s Fertility. Obstet. Gynecol. Surv. 2016, 71, 557–568.
  4. Vercellini, P.; Consonni, D.; Dridi, D.; Bracco, B.; Frattaruolo, M.P.; Somigliana, E. Uterine adenomyosis and in vitro fertilization outcome: A systematic review and meta-analysis. Hum. Reprod. 2014, 29, 964–977.
  5. Gordts, S.; Grimbizis, G.; Campo, R. Symptoms and classification of uterine adenomyosis, including the place of hysteroscopy in diagnosis. Fertil. Steril. 2018, 109, 380–388.e381.
  6. Alcalde, A.M.; Martinez-Zamora, M.A.; Gracia, M.; Ros, C.; Rius, M.; Castelo-Branco, C.; Carmona, F. Assessment of Quality of Life, Sexual Quality of Life, and Pain Symptoms in Deep Infiltrating Endometriosis Patients With or Without Associated Adenomyosis and the Influence of a Flexible Extended Combined Oral Contraceptive Regimen: Results of a Prospective, Observational Study. J. Sex Med. 2022, 19, 311–318.
  7. Harada, T.; Taniguchi, F.; Amano, H.; Kurozawa, Y.; Ideno, Y.; Hayashi, K.; Harada, T.; Japan, E.; Children’s Study, G. Adverse obstetrical outcomes for women with endometriosis and adenomyosis: A large cohort of the Japan Environment and Children’s Study. PLoS ONE 2019, 14, e0220256.
  8. Cope, A.G.; Ainsworth, A.J.; Stewart, E.A. Current and Future Medical Therapies for Adenomyosis. Semin. Reprod. Med. 2020, 38, 151–156.
  9. Yu, O.; Schulze-Rath, R.; Grafton, J.; Hansen, K.; Scholes, D.; Reed, S.D. Adenomyosis incidence, prevalence and treatment: United States population-based study 2006–2015. Am. J. Obstet. Gynecol. 2020, 223, 94.e1–94.e10.
  10. Peric, H.; Fraser, I.S. The symptomatology of adenomyosis. Best Pract. Res. Clin. Obstet. Gynaecol. 2006, 20, 547–555.
  11. Seidman, J.D.; Kjerulff, K.H. Pathologic findings from the Maryland Women’s Health Study: Practice patterns in the diagnosis of adenomyosis. Int. J. Gynecol. Pathol. 1996, 15, 217–221.
  12. Mark, A.S.; Hricak, H.; Heinrichs, L.W.; Hendrickson, M.R.; Winkler, M.L.; Bachica, J.A.; Stickler, J.E. Adenomyosis and leiomyoma: Differential diagnosis with MR imaging. Radiology 1987, 163, 527–529.
  13. Fedele, L.; Bianchi, S.; Dorta, M.; Arcaini, L.; Zanotti, F.; Carinelli, S. Transvaginal ultrasonography in the diagnosis of diffuse adenomyosis. Fertil. Steril. 1992, 58, 94–97.
  14. Bazot, M.; Darai, E. Role of transvaginal sonography and magnetic resonance imaging in the diagnosis of uterine adenomyosis. Fertil. Steril. 2018, 109, 389–397.
  15. Gordts, S.; Brosens, J.J.; Fusi, L.; Benagiano, G.; Brosens, I. Uterine adenomyosis: A need for uniform terminology and consensus classification. Reprod. Biomed. Online 2008, 17, 244–248.
  16. Habiba, M.; Gordts, S.; Bazot, M.; Brosens, I.; Benagiano, G. Exploring the challenges for a new classification of adenomyosis. Reprod. Biomed. Online 2020, 40, 569–581.
  17. Canis, M.; Gremeau, A.S.; Bourdel, N. Elusive adenomyosis: A plea for an international classification system to allow artificial intelligence approaches to reset our clinical management. Fertil. Steril. 2018, 110, 1039–1040.
  18. Tellum, T.; Naftalin, J.; Chapron, C.; Dueholm, M.; Guo, S.W.; Hirsch, M.; Larby, E.R.; Munro, M.G.; Saridogan, E.; van der Spuy, Z.M.; et al. Development of a core outcome set and outcome definitions for studies on uterus-sparing treatments of adenomyosis (COSAR): An international multistakeholder-modified Delphi consensus study. Hum. Reprod. 2022, 37, 2012–2031.
  19. Kishi, Y.; Suginami, H.; Kuramori, R.; Yabuta, M.; Suginami, R.; Taniguchi, F. Four subtypes of adenomyosis assessed by magnetic resonance imaging and their specification. Am. J. Obs. Gynecol. 2012, 207, 114.e111–114.e117.
  20. Kobayashi, H.; Matsubara, S. A Classification Proposal for Adenomyosis Based on Magnetic Resonance Imaging. Gynecol. Obs. Investig. 2020, 85, 118–126.
  21. Harmsen, M.J.; Van den Bosch, T.; de Leeuw, R.A.; Dueholm, M.; Exacoustos, C.; Valentin, L.; Hehenkamp, W.J.K.; Groenman, F.; De Bruyn, C.; Rasmussen, C.; et al. Consensus on revised definitions of Morphological Uterus Sonographic Assessment (MUSA) features of adenomyosis: Results of modified Delphi procedure. Ultrasound Obs. Gynecol. 2022, 60, 118–131.
  22. Exacoustos, C.; Lazzeri, L.; Martire, F.G.; Russo, C.; Martone, S.; Centini, G.; Piccione, E.; Zupi, E. Ultrasound Findings of Adenomyosis in Adolescents: Type and Grade of the Disease. J. Minim. Invasive Gynecol. 2022, 29, 291–299.e1.
  23. Habiba, M.; Benagiano, G. Classifying Adenomyosis: Progress and Challenges. Int. J. Environ. Res Public Health 2021, 18, 12386.
  24. Munro, M.G. Classification and Reporting Systems for Adenomyosis. J. Minim. Invasive Gynecol. 2020, 27, 296–308.
  25. Exacoustos, C.; Morosetti, G.; Conway, F.; Camilli, S.; Martire, F.G.; Lazzeri, L.; Piccione, E.; Zupi, E. New Sonographic Classification of Adenomyosis: Do Type and Degree of Adenomyosis Correlate to Severity of Symptoms? J. Minim. Invasive Gynecol. 2020, 27, 1308–1315.
  26. Bourdon, M.; Oliveira, J.; Marcellin, L.; Santulli, P.; Bordonne, C.; Maitrot Mantelet, L.; Millischer, A.E.; Plu Bureau, G.; Chapron, C. Adenomyosis of the inner and outer myometrium are associated with different clinical profiles. Hum. Reprod. 2021, 36, 349–357.
  27. Van den Bosch, T.; Dueholm, M.; Leone, F.P.; Valentin, L.; Rasmussen, C.K.; Votino, A.; Van Schoubroeck, D.; Landolfo, C.; Installe, A.J.; Guerriero, S.; et al. Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: A consensus opinion from the Morphological Uterus Sonographic Assessment (MUSA) group. Ultrasound Obs. Gynecol. 2015, 46, 284–298.
  28. Van den Bosch, T.; de Bruijn, A.M.; de Leeuw, R.A.; Dueholm, M.; Exacoustos, C.; Valentin, L.; Bourne, T.; Timmerman, D.; Huirne, J.A.F. Sonographic classification and reporting system for diagnosing adenomyosis. Ultrasound Obs. Gynecol. 2019, 53, 576–582.
  29. Sampson, J.A. Perforating hemorrhagic (chocolate) cysts of the ovary. Their importance and especially their relation to pelvic adeno mas of endometrial type. Adenomyoma of the uterus, rectovaginal septum, sigmoid, etc. Arch. Surg. 1921, 3, 245–323.
  30. Cullen, T.S. Adenomyoma of the Uterus; W.B. Saunders: Philadelphia, PA, USA; London, UK, 1908.
  31. Yamaguchi, M.; Yoshihara, K.; Suda, K.; Nakaoka, H.; Yachida, N.; Ueda, H.; Sugino, K.; Mori, Y.; Yamawaki, K.; Tamura, R.; et al. Three-dimensional understanding of the morphological complexity of the human uterine endometrium. iScience 2021, 24, 102258.
  32. Kobayashi, H.; Matsubara, S.; Imanaka, S. Relationship between magnetic resonance imaging-based classification of adenomyosis and disease severity. J. Obs. Gynaecol. Res. 2021, 47, 2251–2260.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Upload a video for this entry
Information
Subjects: Obstetrics & Gynaecology
Contributors MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register : Sun-Wei Guo , Giuseppe Benagiano ,
Marc Bazot
View Times: 939
Revisions: 2 times (View History)
Update Date: 10 Jan 2023
Table of Contents
    1000/1000
    Hot Most Recent
    Notice
    You are not a member of the advisory board for this topic. If you want to update advisory board member profile, please contact office@encyclopedia.pub.
    OK
    Confirm
    Only members of the Encyclopedia advisory board for this topic are allowed to note entries. Would you like to become an advisory board member of the Encyclopedia?
    Yes
    No
    Academic Video Service
    Feedback